Libra Therapeutics
Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative disease
4 employees · est. 2019 · San Diego, United States
QurAlis is the older company (2019 vs 2016); QurAlis is the larger of the two.
Side-by-Side Comparison
| Metric | Libra Therapeutics | QurAlis |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2016 older |
| Headquarters | ||
| Headquarters | San Diego, United States | Cambridge, United States |
| Employees | ||
| Employees | 4 | 89 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Unknown |
| Total Funding | ||
| Total Funding | $29.00M | $160.42M |
| Funding Rounds | ||
| Funding Rounds | 1 | 5 |
| Services | ||
| Services | Development of novel therapeutics, Advancing small molecule-targeted mechanisms, Screening platform for autophagy and lysosomal biogenesis compounds, Clinical development of drugs for neurodegenerative diseases | Development of Precision Medicines, Research in Neurodegenerative Diseases, Advancement of Therapeutic Candidates, Proprietary Anti-Sense Oligonucleotide Platform |
| Target Customers | ||
| Target Customers | Patients suffering from neurodegenerative disorders, Healthcare providers specializing in neurodegeneration, Pharmaceutical and biotech researchers, Medical professionals in neurology and related fields | Patients with ALS, Patients with Neurodegenerative Diseases, Healthcare Providers, Neurology Researchers |
| Taxonomy | ||
| Taxonomy | Neurodegenerative Disease, Therapeutics, Disease-modifying, Small Molecule Drugs, Autophagy, Toxic Proteins, Neurotoxic Proteins, ALS, FTD, Alzheimer's, Parkinson's, Huntington's Disease, Cellular Balance, Drug Development | Neuro Pioneers, Precision Medicine, Neurodegenerative Diseases, ALS, FTD, Innovation, Therapeutic Candidates, Genetic Mutations, Clinical Biomarkers, Harvard Medical School, Biologists, Drug Development |
| Website | ||
| Website | libratherapeutics.com | quralis.com |
About Libra Therapeutics
Libra Therapeutics, founded in 2019 and headquartered in the United States, is a biotechnology company committed to restoring cellular balance in neurodegenerative diseases. Its unique vision, encapsulated in the slogan "Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative...
About QurAlis
QurAlis, founded in 2016, is a biotechnology startup located in the United States, specializing in precision medicines for neurodegenerative diseases. Their slogan, "Neuro Pioneers on a Quest to Cure," encapsulates their mission to transform the treatment landscape for diseases like amyotrophic late...
We will tell you when either one moves
BounceWatch watches Libra Therapeutics and QurAlis for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Libra Therapeutics and QurAlis — by email.
Frequently Asked Questions
Compare Libra Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Libra Therapeutics on 12 Sep 2024, and QurAlis on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.